The Role of cccDNA in HBV Maintenance
暂无分享,去创建一个
[1] F. Zoulim,et al. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. , 2017, Journal of hepatology.
[2] M. Nassal,et al. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation—and Beyond? , 2017, Viruses.
[3] A. Lohse,et al. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo , 2017, Gut.
[4] Jianming Hu,et al. Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application , 2017, Viruses.
[5] T. Volz,et al. Serum HBV pgRNA as a clinical marker for cccDNA activity. , 2017, Journal of hepatology.
[6] M. Manns,et al. Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B. , 2016, The Journal of infectious diseases.
[7] N. Xia,et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. , 2016, Journal of hepatology.
[8] C. Delaugerre,et al. Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. , 2016, Journal of hepatology.
[9] Wenhui Li,et al. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus , 2016, PLoS pathogens.
[10] Yanbao Yu,et al. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication. , 2016, Cell reports.
[11] Xuan Wang,et al. Asymmetric partitioning of transfected DNA during mammalian cell division , 2016, Proceedings of the National Academy of Sciences.
[12] U. Protzer,et al. Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure. , 2016, Journal of hepatology.
[13] S. Fletcher,et al. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor , 2016, Nature.
[14] M. Heikenwalder,et al. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. , 2016, Gastroenterology.
[15] B. McMahon,et al. Present and future therapies of hepatitis B: From discovery to cure , 2015, Hepatology.
[16] L. Calvo,et al. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome , 2015, PloS one.
[17] Meghan M. Holdorf,et al. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation , 2015, Proceedings of the National Academy of Sciences.
[18] Y. Liaw,et al. Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B , 2015, Alimentary pharmacology & therapeutics.
[19] K. Caldecott,et al. Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair? , 2015, PloS one.
[20] M. Nassal. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B , 2015, Gut.
[21] R. Gish,et al. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. , 2015, World journal of gastroenterology.
[22] B. Autran,et al. Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure , 2015, Gut.
[23] M. Heikenwalder,et al. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets , 2015, The Journal of pathology.
[24] T. Berg,et al. Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors , 2015, Hepatology.
[25] A. Bertoletti,et al. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response? , 2014, Medical Microbiology and Immunology.
[26] J. Chen,et al. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss , 2014, Journal of viral hepatitis.
[27] M. Nassal,et al. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses , 2014, Proceedings of the National Academy of Sciences.
[28] T. Liang,et al. Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA , 2014, Science.
[29] A. Lohse,et al. Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. , 2014, Journal of hepatology.
[30] S. Litwin,et al. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. , 2013, Virology.
[31] E. Giang,et al. Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. , 2013, Journal of hepatology.
[32] A. Lohse,et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. , 2013, Journal of hepatology.
[33] Wenhui Li,et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.
[34] D. Vassilopoulos,et al. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir. , 2012, Gastroenterology.
[35] T. Block,et al. Characterization of the Host Factors Required for Hepadnavirus Covalently Closed Circular (ccc) DNA Formation , 2012, PloS one.
[36] A. Lohse,et al. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation , 2012, Hepatology.
[37] M. Levrero,et al. IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. , 2012, The Journal of clinical investigation.
[38] A. Bertoletti,et al. Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Postgraduate Medical Journal.
[39] Fabien Zoulim,et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. , 2011, Journal of hepatology.
[40] A. Lohse,et al. Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. , 2011, Gastroenterology.
[41] H. Blum,et al. Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner , 2010, PLoS pathogens.
[42] U. Protzer,et al. Control of hepatitis B virus at the level of transcription , 2010, Journal of viral hepatitis.
[43] Jinhong Chang,et al. Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus , 2010, Journal of Virology.
[44] S. Litwin,et al. Clonal Expansion of Normal-Appearing Human Hepatocytes during Chronic Hepatitis B Virus Infection , 2010, Journal of Virology.
[45] Hildegard Büning,et al. Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection , 2009, Hepatology.
[46] M. Levrero,et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function , 2009, Proceedings of the National Academy of Sciences.
[47] P. Klenerman,et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.
[48] M. Levrero,et al. Control of cccDNA function in hepatitis B virus infection. , 2009, Journal of hepatology.
[49] S. Litwin,et al. Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.
[50] F. Zoulim,et al. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.
[51] M. Nassal. Hepatitis B viruses: reverse transcription a different way. , 2008, Virus research.
[52] A. Quaas,et al. Sequential Combination Therapy Leads to Biochemical and Histological Improvement Despite Low Ongoing Intrahepatic Hepatitis B virus Replication , 2008, Antiviral therapy.
[53] S. Litwin,et al. Hepatocyte turnover in transient and chronic hepadnavirus infections , 2007, Journal of viral hepatitis.
[54] A. Cuconati,et al. Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation , 2007, Journal of Virology.
[55] A. Quaas,et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. , 2007, Gastroenterology.
[56] M. Kann,et al. Intracellular transport of hepatitis B virus. , 2007, World journal of gastroenterology.
[57] J. Koskinas,et al. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients , 2006, Hepatology.
[58] M. Kann,et al. Lipid-Mediated Introduction of Hepatitis B Virus Capsids into Nonsusceptible Cells Allows Highly Efficient Replication and Facilitates the Study of Early Infection Events , 2006, Journal of Virology.
[59] M. Levrero,et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. , 2006, Gastroenterology.
[60] Junn-Liang Chang,et al. Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. , 2006, Biochemical and biophysical research communications.
[61] M. Yuen,et al. One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels , 2005, Antiviral therapy.
[62] M. Lutgehetmann,et al. Temporary HBV Resolution in an HIV-Coinfected Patient during Hbv-Directed Combination Therapy Followed by Relapse of HBV , 2005, Antiviral therapy.
[63] Bryan Boyd,et al. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] V. Wong,et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. , 2005, Gastroenterology.
[65] J. Summers,et al. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Gibbs,et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.
[67] R. Purcell,et al. Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[68] S. Litwin,et al. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[69] F. Chisari,et al. Transcriptional and posttranscriptional control of hepatitis B virus gene expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] R. Purcell,et al. CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.
[71] L. Wodicka,et al. Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[72] Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication , 2002, Journal of Virology.
[73] M. Manns,et al. Structural organization of the hepatitis B virus minichromosome. , 2001, Journal of molecular biology.
[74] F. Chisari,et al. Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.
[75] H. Will,et al. Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir In vitro do not lead to reduction of the closed circular DNA , 2000, Hepatology.
[76] F. Chisari,et al. Intrahepatic Induction of Alpha/Beta Interferon Eliminates Viral RNA-Containing Capsids in Hepatitis B Virus Transgenic Mice , 2000, Journal of Virology.
[77] M. Shapiro,et al. Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.
[78] H. O'brodovich,et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.
[79] W. Mason,et al. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus , 1997, Journal of virology.
[80] F. Chisari. Cytotoxic T cells and viral hepatitis. , 1997, The Journal of clinical investigation.
[81] F. Chisari,et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.
[82] S. Locarnini,et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes , 1995, Journal of virology.